David Pendarvis - 03 Feb 2023 Form 4 Insider Report for RESMED INC (RMD)

Signature
David Pendarvis, Chief Administrative Officer
Issuer symbol
RMD
Transactions as of
03 Feb 2023
Net transactions value
-$336,750
Form type
4
Filing time
06 Feb 2023, 12:55:16 UTC
Previous filing
05 Jan 2023
Next filing
07 Mar 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RMD ResMed Common Stock Sale $336,750 -1,500 -1.5% $224.50 95,672 03 Feb 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transaction was conducted under a Rule 10b5-1 plan.